Showing results (61-70 of 150) with videos related to
Sort By:
Pageof 15
Journal of Virus Eradication|May 15, 2020
Phase 3 trials of new antiretrovirals are not representative of the global HIV epidemicToby Pepperrell, Andrew Hill, Michelle Moorhouse, et al.Journal of the International AIDS Society|January 31, 2012
Performance evaluation of the Pima™ point-of-care CD4 analyser using capillary blood sampling in field tests in South AfricaDeborah K Glencross, Lindi M Coetzee, Mamsallah Faal, et al.AIDS (London, England)|January 29, 2014
Predicted levels of HIV drug resistance: potential impact of expanding diagnosis, retention, and eligibility criteria for antiretroviral therapy initiationValentina Cambiano, Silvia Bertagnolio, Michael R Jordan, et al.BMC Health Services Research|September 15, 2017
Uptake of health services among truck drivers in South Africa: analysis of routine data from nine roadside wellness centresSamanta Tresha Lalla-Edward, Sydney Ncube, Paul Matthew, et al.BMJ Open|April 14, 2022
Influence of shift work on cardiovascular disease risk in Southern African long-distance truck drivers: a cross-sectional studyMelvin Draaijer, Karine Scheuermaier, Samanta Tresha Lalla-Edward, et al.AIDS (London, England)|May 11, 2018
The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries: what are the issues?Marco Vitoria, Andrew Hill, Nathan Ford, et al.Bjpsych Open|July 14, 2026
Psychiatric symptoms of long COVID among adults: observational case-control study in Johannesburg, South AfricaAndrew Wooyoung Kim, Someleze Swana, Simiso Sokhela, et al.Plos One|January 15, 2020
Usability assessment of seven HIV self-test devices conducted with lay-users in Johannesburg, South AfricaMohammed Majam, Laura Mazzola, Naleni Rhagnath, et al.Southern African Journal of HIV Medicine|February 8, 2023
Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIVEnkosi Mondleki, Clifford G Banda, Nomathemba C Chandiwana, et al.Frontiers in Immunology|February 15, 2021
Differential Responsiveness of the Platelet Biomarkers, Systemic CD40 Ligand, CD62P, and Platelet-Derived Growth Factor-BB, to Virally-Suppressive Antiretroviral TherapyHelen C Steel, W D Francois Venter, Annette J Theron, et al.Pageof 15